ISR Immune System Regulation, an innovation-driven research company based in Stockholm, Sweden, is at the forefront of immunotherapy. Specializing in developing unique treatment platforms, ISR is dedicated to improving global health by providing effective vaccines against a range of infectious diseases, including Covid-19 variants. By challenging established norms in immunology, ISR offers groundbreaking solutions, such as inhaled vaccines, to target specific areas of the body where diseases manifest.

Led by CEO Ola Winqvist, ISR's research extends beyond Covid-19 to encompass protection against viruses like HIV, cancer, and Hepatitis B. With a commitment to advancing immunological research, ISR is shaping the future of vaccination. Follow ISR on Twitter for updates on their projects and stay tuned for more innovative developments.

Join us on the journey towards a healthier world with ISR Immune System Regulation